MedScience Ventures

MedScience Ventures (MSV) is a venture capital and fund management firm with operations spanning the US, Europe, and Asia. The firm was co-founded by five managing partners — Stefano Ciampolini, Sherwyn Hung, Christopher Ford, Nick Wu, and Bret Siarkowski — all of whom bring deep expertise in life sciences, medical devices, dialysis services, pharmaceuticals, and healthcare technology. The firm's tagline is "Bridging Life Sciences and Culture." Beyond equity investing, MSV provides consulting services to portfolio companies and pursues exclusive licensing rights in specific geographic markets. Its geographic reach across three major regions positions it to help companies navigate international market entry, particularly in the US, Europe, and the Asia Pacific region, including Greater China. MSV focuses exclusively on emerging life science and medical technologies. Notable portfolio companies include Digital Diagnostics (formerly 3Derm Systems, an FDA-authorized autonomous AI diagnostics platform), NanoDX (rapid concussion diagnostics), Lumicell (real-time intraoperative cancer detection), Mavencare (home health care), and UV Light Care (UV disinfection for vascular access devices).